Evidence map›Paper›PMID 35311092›Full record

ArticleFrontiers in oncology2022

Eloquent Lower Grade Gliomas, a Highly Vulnerable Cohort: Assessment of Patients' Functional Outcome After Surgery Based on the LoG-Glio Registry.

Jan Coburger, Julia Onken, Stefan Rueckriegel, Christian von der Brelie, Minou Nadji-Ohl, Marie-Therese Forster, Rüdiger Gerlach, Meike Unteroberdörster, Constantin Roder, Katja Kniese and 13 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 1 country.

Jan CoburgerDepartment of Neurosurgery, University of Ulm, Günzburg, Germany.
Julia OnkenDepartment of Neurosurgery, Charité - University of Berlin, Berlin, Germany.
Stefan RueckriegelDepartment of Neurosurgery, University of Würzburg, Würzburg, Germany.
Christian von der BrelieDepartment of Neurosurgery, University of Göttingen, Göttingen, Germany.
Minou Nadji-OhlDepartment of Neurosurgery, Katharinenhospital Stuttgart, Stuttgart, Germany.
Marie-Therese ForsterDepartment of Neurosurgery, University of Frankfurt, Frankfurt am Main, Germany.
Rüdiger GerlachDepartment of Neurosurgery, Helios Hospital Erfurt, Erfurt, Germany.
Meike UnteroberdörsterDepartment of Neurosurgery, Charité - University of Berlin, Berlin, Germany.
Constantin RoderDepartment of Neurosurgery, University of Tübingen, Tübingen, Germany.
Katja KnieseDepartment of Neurosurgery, KRH Klinikum Region Hannover, Hannover, Germany.
Stefan SchommerDepartment of Neurosurgery, Katharinenhospital Stuttgart, Stuttgart, Germany.
Dietrich RothenbacherInstitute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Gabriele NagelInstitute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Christian Rainer WirtzDepartment of Neurosurgery, University of Ulm, Günzburg, Germany.
Ralf-Ingo ErnestusDepartment of Neurosurgery, University of Würzburg, Würzburg, Germany.
Arya NabaviDepartment of Neurosurgery, KRH Klinikum Region Hannover, Hannover, Germany.
Marcos TatagibaDepartment of Neurosurgery, University of Tübingen, Tübingen, Germany.
Marcus CzabankaDepartment of Neurosurgery, University of Frankfurt, Frankfurt am Main, Germany.
Oliver GanslandtDepartment of Neurosurgery, Katharinenhospital Stuttgart, Stuttgart, Germany.
Veit RohdeDepartment of Neurosurgery, University of Göttingen, Göttingen, Germany.
Mario LöhrDepartment of Neurosurgery, University of Würzburg, Würzburg, Germany.
Peter VajkoczyDepartment of Neurosurgery, Charité - University of Berlin, Berlin, Germany.
Andrej PalaDepartment of Neurosurgery, University of Ulm, Günzburg, Germany.
Charité - Universitätsmedizin Berlin · DEKatharinenhospital · DEUniversität Ulm · DEUniversity of Würzburg · DEGoethe University Frankfurt · DEKlinikum Region Hannover · DEUniversity of Göttingen · DEUniversity of Tübingen · DEZimmer Biomet (Germany) · DEHelios Klinikum Erfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Majority of lower grade glioma (LGG) are located eloquently rendering surgical resection challenging. Aim of our study was to assess rate of permanent deficits and its predisposing risk factors. We retrieved 83 patients harboring an eloquently located LGGs from the prospective LoG-Glio Database. Patients without surgery or incomplete postoperative data were excluded. Sign rank test, explorative correlations by Spearman ρ and multivariable regression for new postoperative deficits were calculated. Eloquent region involved predominantly motor (45%) and language (40%). At first follow up after 3 months permanent neuro-logical deficits (NDs) were noted in 39%. Mild deficits remained in 29% and severe deficits in 10%. Complete tumor removal (CTR) was successfully in 62% of intended cases. Postoperative and 3-month follow up National Institute of Health Stroke Score (NIHSS) showed significantly lower values than preoperatively (p<0.001). 38% cases showed a decreased NIHSS at 3-month, while occurrence was only 14% at 9-12-month follow up. 6/7 patients with mild aphasia recovered after 9-12 months, while motor deficits present at 3-month follow up were persistent in majority of patients. Eastern oncology group functional status (ECOG) significantly decreased by surgery (p < 0.001) in 31% of cases. Between 3-month and 9-12-months follow up no significant improvement was seen. In the multivariable model CTR (p=0.019, OR 31.9), and ECOG>0 (p=0.021, OR 8.5) were independent predictors for permanent postoperative deficit according to NIHSS at 3-month according to multivariable regression model. Patients harboring eloquently located LGG are highly vulnerable for permanent deficits. Almost one third of patients have a permanent reduction of their functional status based on ECOG. Risk of an extended resection has to be balanced with the respective oncological benefit. Especially, patients with impaired pre-operative status are at risk for new permanent deficits. There is a relevant improvement of neurological symptoms in the first year after surgery, especially for patients with slight aphasia.

Indexed as

awake surgeryeloquent area surgeryeloquent area tumoursiMRI = intraoperative MRIintraoperative monitoring (IOM)iUS = intraoperative ultrasoundLGGneurological deficit

Identifiers

PMID35311092
PMCPMC8927728
OpenAlexW4214907234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.